Enhanced potency of the polymeric fluoropyrimidine CF10 to KRAS-mutant colorectal cancer cells

被引：0

作者：

Gmeiner, William H. ^{[1
]}

Manandhar, Mandira ^{[1
]}

Hinds, Amanda M. ^{[1
]}

Holmes, Julija ^{[1
]}

Vidi, Pierre ^{[1
]}

Tsunoda, Toshiyuki ^{[2
]}

Shirasawa, Senji ^{[2
]}

机构：

[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA

[2] Fukuoka Univ, Fac Med, Fukuoka, Fukuoka, Japan

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-2079

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2079

引用

页数：2

共 50 条

[41] Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling
Zhou, Xinghua
Kang, Jian
Zhang, Liangliang
Cheng, Yue
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (02) : 119 - 134
[42] BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer
Bartolini, Alice
Cardaci, Sabrina
Lamba, Simona
Oddo, Daniele
Marchio, Caterina
Cassoni, Paola
Amoreo, Carla Azzurra
Corti, Giorgio
Testori, Alessandro
Bussolino, Federico
Pasqualini, Renata
Arap, Wadih
Cora, Davide
Di Nicolantonio, Federica
Marchio, Serena
CLINICAL CANCER RESEARCH, 2016, 22 (19) : 4923 - 4933
[43] Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner
Georgios Vlachogiannis
Alexis De Haven Brandon
Melanie Valenti
Gary Box
Liam Jenkins
Caterina Mancusi
Annette Self
Floriana Manodoro
Ioannis Assiotis
Penny Robinson
Ritika Chauhan
Alistair G. Rust
Nik Matthews
Kate Eason
Khurum Khan
Naureen Starling
David Cunningham
Anguraj Sadanandam
Clare M. Isacke
Vladimir Kirkin
Nicola Valeri
Steven R. Whittaker
Oncogene, 2019, 38 : 5746 - 5746
[44] Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer
Bian, Yujia
Alem, Diego
Beato, Francisca
Hogenson, Tara L.
Yang, Xinrui
Jiang, Kun
Cai, Jianfeng
Ma, Wen Wee
Fernandez-Zapico, Martin
Tan, Aik Choon
Lawrence, Nicholas J.
Fleming, Jason B.
Yuan, Yu
Xie, Hao
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (24) : 16432 - 16450
[45] DNA Origami-Cyanine Nanocomplex for Precision Imaging of KRAS-Mutant Pancreatic Cancer Cells
Moon, Hye-ran
Du, Yancheng
Choi, Sae Rome
Seo, Seongmin
Cheng, Cih
Elzey, Bennett D.
Choi, Jong Hyun
Han, Bumsoo
ADVANCED SCIENCE, 2025,
[46] KRAS-mutant colon cancer cells respond to combined treatment of ABT263 and axitinib
Wang, Guihua
Huang, Ying
Wu, Zhipeng
Zhao, Chunmei
Cong, Hui
Ju, Shaoqing
Wang, Xudong
BIOSCIENCE REPORTS, 2019, 39
[47] Platycodin D sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the PI3K/Akt signaling pathway
Liu, Yanfei
Tian, Shifeng
Yi, Ben
Feng, Zhiqiang
Chu, Tianhao
Liu, Jun
Zhang, Chunze
Zhang, Shiwu
Wang, Yijia
FRONTIERS IN ONCOLOGY, 2022, 12
[48] Combined treatment of ABT199 and irinotecan suppresses KRAS-mutant lung cancer cells
Xu, Yinhai
Zong, Shuai
Gao, Xin
Zhang, Haoliang
Wang, Bin
Li, Pengpeng
Liu, Tielong
Li, Shibao
GENE, 2019, 688 : 1 - 6
[49] The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer
Wong, Chi Chun
Wu, Jian-Lin
Ji, Fenfen
Kang, Wei
Bian, Xiqing
Chen, Huarong
Chan, Lam-Shing
Luk, Simson Tsz Yat
Tong, Samuel
Xu, Jiaying
Zhou, Qiming
Liu, Dabin
Su, Hao
Gou, Hongyan
Cheung, Alvin Ho-Kwan
To, Ka Fai
Cai, Zongwei
Shay, Jerry W.
Yu, Jun
NATURE COMMUNICATIONS, 2022, 13 (01)
[50] The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer
Chi Chun Wong
Jian-Lin Wu
Fenfen Ji
Wei Kang
Xiqing Bian
Huarong Chen
Lam-Shing Chan
Simson Tsz Yat Luk
Samuel Tong
Jiaying Xu
Qiming Zhou
Dabin Liu
Hao Su
Hongyan Gou
Alvin Ho-Kwan Cheung
Ka Fai To
Zongwei Cai
Jerry W. Shay
Jun Yu
Nature Communications, 13

← 1 2 3 4 5 →